The role of monoamine metabolism in oxidative glutamate toxicity

Journal of Neuroscience

Volumn 16, Issue 20, 1996, Pages 6394-6401

  Maher, Pamela ^a   Davis, John B ^b,c  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

dopamine; free radicals; glutamate toxicity; hydrogen peroxide; monoamine oxidase; neuronal cells; Parkinson's disease

Indexed keywords

ALAPROCLATE; AMINE OXIDASE (FLAVIN CONTAINING); BENZAMIDE DERIVATIVE; CLOMIPRAMINE; CLORGYLINE; DIZOCILPINE; DOPAMINE; DOXEPIN; FREE RADICAL; GLUTAMIC ACID; HARMINE; HYDRALAZINE; HYDROGEN PEROXIDE; IMIPRAMINE; INDATRALINE; MEPACRINE; MONOAMINE OXIDASE INHIBITOR; N (2 AMINOETHYL) 4 CHLOROBENZAMIDE; N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE; PARGYLINE; PIRLINDOLE; SELEGILINE; TC 715; TC 724; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DEGENERATIVE DISEASE; ENZYME INHIBITION; HIPPOCAMPUS; MONOAMINE METABOLISM; MOUSE; NERVE CELL CULTURE; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0029844831     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-20-06394.1996     Document Type: Article

References (49)

1. Ames BN, Shigenaga MK (1992) Oxidants are a major contributor to aging, Ann NY Acad Sci 663:85-96.
2. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 130:1910-1917.
3. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77:817-822.
4. Bergman H, Wichmann T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249:1436-1438.
5. Bottenstein J, Sato G (1979) Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc Natl Acad Sci USA 76:514-517.
6. Cathcart R, Schwiers E, Ames BN (1983) Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay. Anal Biochem 134:111-116.
7. Cawthon RM, Pintar JE, Haseltine FP, Breakefield XO (1981) Differences in the structure of A and B forms of human monoamine oxidase. J Neurochem 37:363-372.
8. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623-634.
9. Choi DW (1992) Excitotoxic cell death. J Neurobiol 23:1261-1276.
10. Cook JA, Mitchell JB (1989) Viability measurements in mammalian cell systems. Anal Biochem 179:1-7.
11. Cross AR (1990) Inhibitors of the leukocyte superoxide generating oxidase. Free Radic Biol Med 8:71-93.
12. Davis JB, Maher P (1994) Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell lines. Brain Res 652:169-173.
13. Edelstein SB, Breakefield XO (1981) Dexamethasone selectively increases monoamine oxidase type A in human skin fibroblasts. Biochem Biophys Res Commun 98:836-843.
14. Erdo SL, Michler A, Wolff JR, Tytko H (1990) Lack of excitotoxic cell death in serum-free cultures of rat cerebral cortex. Brain Res 526:328-332.
15. Froissard P, Duval D (1994) Cytotoxic effects of glutamic acid on PC12 cells. Neurochem Int 24:485-493.
16. Greenamyre JT, Penney JB, Young AB, Amato CJ, Hicks SP, Shoulson I (1985) Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases. Science 227:1496-1499.
17. Greene JG, Greenamyre JT (1995) Exacerbation of NMDA, AMPA and L-glutamate excitotoxicity by the succinate dehydrogenase inhibitor malonate. J Neurochem 64:2332-2338.
18. Gwag BJ, Lobner D, Koh JY, Wie MB, Choi DW (1995) Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neuroscience 68:615-619.
19. Halliwell B, Gutteridge JMC (1993) Free radicals in biology and medicine. New York: Oxford.
20. Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119:203-210.
21. Hasegawa E, Takeshige K, Oishi T, Murai Y, Minakami S (1990) 1-Methyl-4-phenylpyridimium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles. Biochem Biophys Res Commun 170:1049-1055.
22. Huettner JE, Baughman RW (1986) Primary culture of identified neurons from the visual cortex of postnatal rats. J Neurosci 6:3044-3060.
23. Jenner P (1994) Oxidative damage in neurodegenerative diseases. Lancet 344:796-798.
24. Jonsson G (1971) Quantitation of fluorescence of biogenic monoamines. Prog Histochem Cytochem 2:299-344.
25. Kitayama S, Dohi T, Uhl GR (1994) Phorbol esters alter functions of the expressed dopamine transporter. Eur J Pharmacol 268:115-119.
26. Lees GJ (1993) Contributory mechanisms in the causation of neurodegenerative diseases. Neuroscience 54:287-322.
27. Mavelli I, Rigo A, Federico R, Ciriolo MR, Rotillo G (1982) Superoxide dismutase, glutathione peroxidase and catalase in the developing rat brain. Biochem J 204:535-540.
28. Michaels RL, Rothman SM (1990) Glutamate neurotoxicity in vitro: antagonist pharmacology and intracellular calcium concentrations. J Neurosci 10:283-292.
29. Michel PP, Hefti F (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J Neurosci Res 26:428-435.
30. Miyamoto M, Murphy TH, Schnaar RL, Coyle JT (1989) Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther 250:1132-1140.
31. Moreadith RW, Fiskum G (1984) Isolation of mitochondria from ascites tumor cells permeabilized with digitonin. Anal Biochem 137:360-367.
32. Morimoto BH, Koshland DE (1990) Induction and expression of long and short term neurosecretory potentiation in a neural cell line. Neuron 5:875-880.
33. Murphy TH, Miyamoto M, Sastre A, Schnaar RL, Coyle JT (1989) Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron 2:1547-1558.
34. Murphy TH, Schnaar RL, Coyle JT (1990) Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J 4:1624-1633.
35. Oka A, Belliveau MJ, Rosenberg PA, Volpe JJ (1993) Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms and prevention. J Neurosci 13:1441-1453.
36. Olney JW (1969) Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 164:719-721.
37. Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ, Cadet JL (1992) Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced neurotoxicity. J Neurosci 12:1658-1667.
38. Richelson E (1994) Pharmacology of antidepressants: characteristics of the ideal drug. Mayo Clin Proc 69:1069-1081.
39. 14C]-deprenyl. Mol Pharmacol 16:234-241.
40. Schubert D, LaCorbiere M, Klier FG, Steinbach JH (1980) The modulation of neurotransmitter synthesis by steroid hormones and insulin. Brain Res 190:67-75.
41. Schubert D, Kimura H, Maher P (1992) Growth factors and vitamin E modify neuronal glutamate toxicity. Proc Natl Acad Sci USA 89:8264-8267.
42. Singer TP, Ramsay RR (1995) Monoamine oxidases: old friends hold many surprises. FASEB J 9:605-610.
43. Sonsalla PK, Nicklas WJ, Heikkila RE (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243:398-400.
44. Spina M-B, Cohen G (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc Natl Acad Sci USA 86:1398-1400.
45. Turski L, Bressler K, Rettig K-J, Loschmann P-A, Wachtel H (1991) Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D aspartate antagonists. Nature 349:414-418.
46. Vornov JJ, Coyle JT (1991) Glutamate neurotoxicity and the inhibition of protein synthesis in the hippocampal slice. J Neurochem 56:996-1006.
47. 2O release assessed by charcoal adsorption. J Neurosci Methods 48:123-129.
48. Weyler W, Hsu Y-PP, Breakefield XO (1990) Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 47:391-417.
49. Wurtman RJ, Axelrod J (1963) A sensitive and specific assay for estimation of monoamine oxidase. Biochem Pharmacol 12:1439-1445.